Company Overview of CT Atlantic Ltd.
CT Atlantic, Ltd., a biotechnology company, engages in the identification and development of human-derived antibodies for the treatment of cancer. The company was founded in 2008 and is based in Zurich, Switzerland.
Founded in 2008
Key Executives for CT Atlantic Ltd.
Similar Private Companies By Industry
|Angiotech International AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact CT Atlantic Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.